NeuroVice

NeuroVice is a private medical device company developing and commercializing seizure-management products for patients with epilepsy and other seizure disorders. Its lead and currently identified commercial product is PATI, an FDA-cleared single-use oral device intended to protect the teeth, lips, tongue, and buccal mucosa during seizures while supporting saliva drainage and airway management. The company positions PATI for use in both clinical settings, such as hospitals and EEG labs, and non-clinical settings including the home. NeuroVice appears focused on patient-centered neurological symptom-management rather than drug development, with commercialization support including prescription fulfillment through BlinkRx.